Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

Share Price is delayed by 15 minutes
Get Live Data
390.00    -1.00 (-0.26%)
Bid:
390.00
Ask:
392.00
Spread: 2.00 (0.513%)
Market Cap: £498.18m
NAS Live PriceLast checked at - London Stock Exchange

Intraday North Atl.smlr Share Chart

Half Yearly Report

10 Sep 2015 18:15

RNS Number : 7517Y
North Atlantic Smlr Co Inv Tst PLC
10 September 2015
Β 

ο»Ώ

North Atlantic Smaller Companies Investment Trust plc

Half-Yearly Report for the six months ended 31 July 2015

Β 

objective of the company and financial highlights

The objective of the Company is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

31 July2015

(unaudited)

31 January2015

(audited)

%

Change

Net asset value per 5p Ordinary Share*:

Β 

Β 

Β 

Basic

2,527p

2,262p

11.7

Diluted

2,525p

2,259p

11.8

Basic adjusted#‑

2,568p

2,300p

11.7

Diluted adjusted#‑

2,566p

2,297p

11.7

Mid-market price of the 5p Ordinary Shares

2,043p

1,845p

10.7

Discount to diluted net asset value

19.1%

18.3%

Β 

Discount to diluted adjusted net asset value

20.4%

19.7%

Β 

Standard & Poor's 500 Composite Index†

1,346.7

1,324.7

1.7

Russell 2000 Index†

792.9

773.8

2.5

FTSE All-Share Index

3,652.8

3,621.8

0.9

US Dollar/Sterling exchange rate

1.5605

1.5019

3.9

* Including retained revenue for the period.

# Adjusted to reflect Oryx International Growth Fund plc ("Oryx") under the equity method of accounting, which is how the Company previously accounted for its share ofΒ Oryx, prior to the adoption of IFRS 10.

‑ Calculated using the adjusted Net Assets per note 5.

† Sterling adjusted.

Β 

Β 

chief executive's review

During the six month period to 31 July 2015, the fully diluted net asset value of the Company rose by 11.8% as compared to a rise in the sterling adjusted Standard & Poor's 500 Composite Index of +1.7% and the FTSE Small Cap Index of +6.5%.

Income for the period amounted to a loss of Β£688,000 (31 July 2014: loss of Β£1,220,000). Consistent with past policy, the Directors do not propose to pay a dividend (31 July 2014: nil).

quoted portfolio

The market for small companies in the UK has generally been robust which benefitted our holding in Oryx which rose by 17.7%, significantly outperforming its benchmark index.

Our very substantial holding in MJ Gleeson Group also performed notably well, rising by nearly 25% over the period. Nationwide Accident Repair Services and Essenden were both taken over on premiums of 28% and 23% respectively to the 31 January 2015 valuation, whilst Bioquell performed very strongly following the sale of a subsidiary, rising by nearly 65%. The only notable faller in the UK was Goals Soccer Centres which fell approximately 7%. Finally, Mecom Group was taken over at a good premium to cost whilst OMG announced substantial special dividends as a return of capital.

In the US a modest position was taken in Ambac Financial Group, although to date the performance has been disappointing.

unquoted portfolio

There has been considerable activity in the unquoted portfolio, with Celsis AG in particular being sold in July 2015 at a 50% premium to the 31 January 2015 valuation.

Avenue Financial went public and is currently trading at approximately a 26% premium to the 31 January 2015 valuation, whilst the B&G Equipment valuation was increased, reflecting good trading performance. Performance Chemical Company, despite the weak oil price, continues to achieve good profitability. The Bionostics Holdings escrow of approximately Β£4.0 million was received in full.

Trident Private Equity Fund II was, to all intents and purposes, liquidated. It was, however, necessary to modestly write down Hampton Investment Properties due to the disappointing realisation of properties. It is expected that this investment will be turned into cash by 31 January 2016, being the Company's year-end.

outlook

Since 31 July 2015, markets have been extremely weak. However, the Company has for some time been very conservatively invested with cash balances in excess of 30% of our net assets. Although this adversely impacted performance in the first half of the year, it will hopefully protect the portfolio during the current turbulence and provide the resources with which to participate in new opportunities as they arise.

C H B Mills

Chief Executive

10 September 2015

Β 

top ten investments

as at 31 July 2015

Company

Fair

value

Β£'000

% of

net assets

US Treasury Bills

US Treasury Stock

65,643

17.9

MJ Gleeson Group plc

UK Listed

45,400

12.4

Oryx International Growth Fund Limited

UK Listed

39,440

10.7

Trident Private Equity Fund III LP

UK Unquoted

20,543

5.6

Industrial Properties Limited

UK Unquoted

14,000

3.8

Bioquell PLC

UK Listed

13,348

3.6

Goals Soccer Centres plc

UK Quoted onΒ AIM

12,672

3.4

Innovation Group PLC

UK Listed

11,288

3.1

AssetCo plc

UK Quoted onΒ AIM

10,373

2.8

Team Rock Limited

UK Unquoted

10,108

2.8

242,815

66.1

Β 

Β 

interim management report

investment objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

material events

The Board do not consider that there were any material events during the period ended 31 July 2015.

material transactions

As referred to in the Chief Executive's review, the Company's investment in Celsis AG was sold during the period under review.

risk profile

The principal risks and uncertainties for the remaining six months of the year continue to be as described in the Annual Report for the year ended 31 January 2015. The principal risks arising from the Company's financial instruments are market price risk, including currency risk interest rate risk and other price risk, liquidity risk and credit/counterparty risk. The Directors review and agree policies with the Manager, Harwood Capital LLP, for managing these risks. The policies have remained substantially unchanged in the six months since the year end.

The Group does not have any significant exposure to credit risk arising from any one individual party. Credit risk is spread across a number of companies, each having an immaterial effect on the Group's cash flows, should a default occur. The Group assesses the credit worthiness of its debtors from time to time to ensure that they are neither past due or impaired.

To support its investment in unquoted companies, the Group may periodically agree to guarantee all or part of the borrowings of investee companies. Provision is made for any costs that may be incurred when the Directors consider it likely that the guarantee will crystallise.

The Group's exposure to market price risk comprises mainly movements in the value of the Group's investments. It should be noted that the prices of options tend to be more volatile than the prices of the underlying securities. The Manager assesses the exposure to market risk when making each investment decision and monitors the overall level of market risk on the whole of the investment portfolio on an ongoing basis.

The functional and presentational currency of the Group is Sterling, and therefore, the Group's principal exposure to foreign currency risk comprises investments priced in other currencies, principally US Dollars.

The Group invests in equities and other investments that are realisable.

related party transactions

These are listed in note 10 to the half yearly condensed financial statements.

By Order of the Board

Peregrine Moncreiffe

Chairman

10 September 2015

Β 

responsibility statement

The Directors confirm to the best of their knowledge that:

Β· The condensed set of financial statements contained within this half yearly financial report have been prepared in accordance with International Accounting Standard 34 'Interim Financial Reporting' as adopted by the European Union and gives a true and fair view of the assets, liabilities, financial position and profit of the Group; and

Β· The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.7R being disclosure of important events that have occurred during the first six months of the financial year, their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the year; and

Β· The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.8R being disclosure of related party transactions during the first six months of the financial year, how they have materially affected the financial position of the Company during the period and any changes therein.

The half yearly financial report was approved by the Board on 10Β September 2015 and the above responsibility statement was signed on its behalf by:

Peregrine Moncreiffe

Chairman

10 September 2015

Β 

condensed consolidated statement of comprehensive income

Β 

Six months ended

31 July

2015

(unaudited)

Six months ended

31 July

2014

(unaudited)

Year ended

31 January

2015

(audited)

RevenueΒ 

Β£'000Β 

CapitalΒ 

Β£'000Β 

TotalΒ 

Β£'000Β 

RevenueΒ 

Β£'000Β 

CapitalΒ 

Β£'000Β 

TotalΒ 

Β£'000Β 

RevenueΒ 

Β£'000Β 

Capital

Β£'000

TotalΒ 

Β£'000Β 

Income

1,279Β 

-Β 

1,279Β 

860Β 

-Β 

860Β 

1,840Β 

-

1,840Β 

Net gains on investments at fairΒ value

-Β 

40,432Β 

40,432Β 

-Β 

11,427Β 

11,427Β 

-Β 

37,873

37,873Β 

Currency exchange (losses)/gains

-Β 

(70)

(70)

-Β 

(119)

(119)

-Β 

270

270Β 

total income

1,279Β 

40,362Β 

41,641Β 

860Β 

11,308Β 

12,168Β 

1,840Β 

38,143

39,983Β 

Expenses

Investment management feeΒ (noteΒ 10)

(1,672)

(937)

(2,609)

(1,632)

26Β 

(1,606)

(3,263)

79

(3,184)

Other expenses

(281)

-Β 

(281)

(261)

-Β 

(261)

(574)

-

(574)

Share based remuneration

(7)

-Β 

(7)

(180)

-Β 

(180)

(173)

-

(173)

return before finance costs andΒ taxation

(681)

39,425Β 

38,744Β 

(1,213)

11,334Β 

10,121Β 

(2,170)

38,222

36,052Β 

Finance costs

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-

-Β 

return before taxation

(681)

39,425Β 

38,744Β 

(1,213)

11,334Β 

10,121Β 

(2,170)

38,222

36,052Β 

Taxation

(7)

-Β 

(7)

(7)

-Β 

(7)

(12)

-

(12)

return for the period

(688)

39,425Β 

38,737Β 

(1,220)

11,334Β 

10,114Β 

(2,182)

38,222

36,040Β 

earnings per ordinary share (note 4)

Basic

266.4p

65.6p

240.3p

Diluted

266.2p

65.3p

240.3p

Β 

The total column of the statement is the Statement of Comprehensive Income of the Group prepared in accordance with International Financial Reporting Standards ("IFRS"). The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice issued by the Association of Investment Companies ("AIC").

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.

Β 

condensed consolidated statement of changes in equity

Β 

ShareΒ 

capitalΒ 

Β£'000Β 

ShareΒ 

optionsΒ 

reserveΒ 

Β£'000Β 

Share

premium

account

Β£'000

Capital

reserve

Β£'000

Capital

redemption

reserve

Β£'000

RevenueΒ 

reserveΒ 

Β£'000Β 

TotalΒ 

Β£'000Β 

six months ended 31 July 2015 (unaudited)

31 January 2015

727Β 

293Β 

1,301

333,262

143

(6,822)

328,904Β 

Total comprehensive income for the period

-Β 

-Β 

-

39,425

-

(688)

38,737Β 

Share option discharge

-Β 

(15)

-

(88)

-

-Β 

(103)

Shares purchased for cancellation

-Β 

-Β 

-

-

-

-Β 

-Β 

Share options expenses

-Β 

7Β 

-

-

-

-Β 

7Β 

31 July 2015

727Β 

285Β 

1,301

372,599

143

(7,510)

367,545Β 

six months ended 31 July 2014 (unaudited)

31 January 2014*

794Β 

1,138Β 

1,301

319,888

76

(4,640)

318,557Β 

Total comprehensive income for the period

-Β 

-Β 

-

11,334

-

(1,220)

10,114Β 

Shares purchased for cancellation

(53)

-Β 

-

(18,080)

53

-Β 

(18,080)

Share options expenses

-Β 

180Β 

-

-

-

-Β 

180Β 

31 July 2014

741Β 

1,318Β 

1,301

313,142

129

(5,860)

310,771Β 

year ended 31 January 2015 (audited)

31 January 2014*

794Β 

1,138Β 

1,301

319,888

76

(4,640)

318,557Β 

Total comprehensive income for the year

-Β 

-Β 

-

38,222

-

(2,182)

36,040Β 

Share option discharge

-Β 

(1,018)

-

(2,081)

-

-Β 

(3,099)

Shares purchased for cancellation

(67)

-Β 

-

(22,767)

67

-Β 

(22,767)

Share option expenses

-Β 

173Β 

-

-

-

-Β 

173Β 

31 January 2015

727Β 

293Β 

1,301

333,262

143

(6,822)

328,904Β 

Β 

* restated due to the adoption of IFRS 10. The Company is no longer required to consolidate investment entities, as explained in the Accounting Policies (note 1) in the Annual Report for the year end 31 January 2015.

Β 

condensed consolidated balance sheet

Β 

31 JulyΒ 

2015Β 

(unaudited)Β 

Β£'000Β 

31 JulyΒ 

2014Β 

(unaudited)Β 

Β£'000Β 

31 JanuaryΒ 

2015Β 

(audited)Β 

Β£'000Β 

non current assets

Investments at fair value through profit or loss

314,656Β 

283,929Β 

321,044Β 

314,656Β 

283,929Β 

321,044Β 

current assets

Trade and other receivables

809Β 

732Β 

562Β 

Cash and cash equivalents

53,489Β 

26,398Β 

7,598Β 

54,298Β 

27,130Β 

8,160Β 

total assets

368,954Β 

311,059Β 

329,204Β 

current liabilities

Trade and other payables

(1,409)

(288)

(300)

total liabilities

(1,409)

(288)

(300)

total assets less current liabilities

367,545Β 

310,771Β 

328,904Β 

net assets

367,545Β 

310,771Β 

328,904Β 

represented by:

Share capital

727Β 

741Β 

727Β 

Share options reserve

285Β 

1,318Β 

293Β 

Share premium account

1,301Β 

1,301Β 

1,301Β 

Capital reserve

372,599Β 

313,142Β 

333,262Β 

Capital redemption reserve

143Β 

129Β 

143Β 

Revenue reserve

(7,510)

(5,860)

(6,822)

total equity attributable to equity holders of the Company

367,545Β 

310,771Β 

328,904Β 

net asset value per ordinary share (note 5):

Basic

2,527p

2,097p

2,262p

Diluted

2,525p

2,078p

2,259p

Β 

Β 

condensed consolidated cash flow statement

Β 

Six monthsΒ 

ended 31 JulyΒ 

2015Β 

(unaudited)Β 

Β£'000Β 

Six monthsΒ 

ended 31 JulyΒ 

2014Β 

(unaudited)Β 

Β£'000Β 

Year endedΒ 

31 JanuaryΒ 

2015Β 

(audited)Β 

Β£'000Β 

cash flows from operating activities

Investment income received

861Β 

880Β 

1,658Β 

Bank deposit interest received

-Β 

28Β 

37Β 

Other income

425Β 

34Β 

215Β 

Investment Manager's fees paid

(1,739)

(3,364)

(5,058)

Other cash payments

(321)

(559)

(3,633)

cash expended fromΒ operations (note 7)

(774)

(2,981)

(6,781)

Taxation paid

(7)

(7)

(12)

net cash outflow from operatingΒ activities

(781)

(2,988)

(6,793)

cash flows from investing activities

Purchases of investments

(186,975)

(109,537)

(309,650)

Sales of investments

233,790Β 

129,588Β 

319,054Β 

net cash inflow from investingΒ activities

46,815Β 

20,051Β 

9,404Β 

cash flows from financing activities

Repurchase of ordinary shares for cancellation

-Β 

(18,068)

(22,769)

net cash outflow from financingΒ activities

-Β 

(18,068)

(22,769)

increase/(decrease) in cash and cash equivalents for the period

46,034Β 

(1,005)

(20,158)

cash and cash equivalents at the start of the period

7,598Β 

27,511Β 

27,511Β 

Revaluation of foreign currency balances

(143)

(108)

245Β 

cash and cash equivalents at the end of the period

53,489Β 

26,398Β 

7,598Β 

Β 

Β 

notes

1. a) general information

North Atlantic Smaller Companies Investment Trust plc ("NASCIT") is a Company incorporated in Great Britain and registered in England and Wales under the Companies Acts 1948 to 1967.

The Company operates as an investment trust company within the meaning of Section 833 of the Companies Act 2006 and has made a successful application under Regulation 5 of the Investment Trust (Approved Company) (Tax) Regulations 2011 for investment trust status to apply to all accounting periods starting on or after 1 February 2013. The Company is managed in such a way to ensure that it continues to meet the eligibility conditions contained in Section 1158 of the Corporation Tax Act 2010 and the ongoing requirements outlined in Chapter 3 of Part 2 of the regulations.

b) basis of preparation

The condensed consolidated interim financial statements for the six months ended 31 July 2015 have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all financial information required for full annual financial statements and have been prepared using the accounting policies adopted in the audited financial statements for the year ended 31Β January 2015. Those financial statements were prepared in accordance with IFRS and with the Statement of Recommended Practice ('SORP') for Investment Companies and Venture Capital Trusts issued by the AIC in November 2014.

The condensed consolidated interim financial information includes the financial statements of the Company and its wholly owned Subsidiary, Consolidated Venture Finance Limited, for the six months ended 31Β July 2015.

c) significant accounting policies

The accounting policies applied are consistent with those of the Annual Financial Report for the year ended 31 January 2015. Since the year end no new standards have been adopted.

d) segmental reporting

The Directors are of the opinion that the Group is engaged in a single segment of business, being investment business. The Group invests in smaller companies principally based in countries bordering the North Atlantic Ocean.

e) going concern

The Company has adequate financial resources and no significant investment commitments and as a consequence, the Directors believe that the Company is well placed to manage its business risks successfully. After making appropriate enquiries, the Directors have a reasonable expectation that the Company has adequate available financial resources to continue in operational existence for the foreseeable future and accordingly have concluded that it is appropriate to continue to adopt the going concern basis in preparing this half yearly financial report.

2. investment management and performance fees

A Performance Fee is only payable if the investment portfolio, including Oryx at the adjusted price, outperforms the Sterling adjusted Standard & Poor's 500 Composite Index at the end of each financial year and is limited to a maximum payment of 0.5% of Shareholders' Funds, and is allocated 100% to capital.

In accordance with the SORP for investment trust companies, an amount is included in these financial statements for the Performance Fee that could be payable based on investment performance to 31 July 2015.

At that date, a Performance Fee has been accrued for in the accounts amounting to Β£937,000 (31 July 2014: Β£nil; 31 January 2015: Β£nil).

3. taxation

The Company has an effective tax rate of 0%. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income and thus there is no charge for corporation tax.

Β 

4. return per ordinary share

Β 

*NetΒ 

returnΒ 

Β£'000Β 

Revenue

Β 

Ordinary

Shares

Per

Share

pence

*Net

return

Β£'000

Capital

Β 

Ordinary

Shares

Per

Share

pence

*Net

return

Β£'000

Total

Β 

Ordinary

Shares

Per

Share

pence

six months ended 31 July 2015 (unaudited)

Basic return

(688)

14,542,035

(4.7)

39,425

14,542,035

271.1

38,737

14,542,035

266.4

Share options**

-Β 

10,442

-

10,442

-

10,442

Diluted return

(688)

14,552,477

(4.7)

39,425

14,552,477

270.9

38,737

14,552,477

266.2

six months ended 31 July 2014 (unaudited)

Basic return

(1,220)

15,409,406

(7.9)

11,334

15,409,406

73.5

10,114

15,409,406

65.6

CULS***

-Β 

66,957

-

66,957

-

66,957

Diluted return

(1,220)

15,476,363

(7.9)

11,334

15,476,363

73.2

10,114

15,476,363

65.3

year ended 31 January 2015 (audited)

Basic return

(2,182)

14,996,362

(14.6)

38,222

14,996,362

254.9

36,040

14,996,362

240.3

Share options**

-Β 

-

-

-

-

-

Diluted return

(2,182)

14,996,362

(14.6)

38,222

14,996,362

254.9

36,040

14,996,362

240.3

Β 

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

* Net return on ordinary activities attributable to Ordinary Shareholders.

** Excess of total number of potential shares on Option Conversion over the number that could be issued at the average market price, as calculated in accordance with IAS 33: Earnings per share.

*** CULS interest cost and excess of the total number of potential shares on CULS conversion over the number that could have been issued at the average market price from the conversion proceeds, as calculated in accordance with IAS 33: Earnings per share.

Β 

Β 

5. net asset value per ordinary share

The basic net asset value per Ordinary Share is based on net assets of Β£367,545,000 (31Β July 2014: Β£310,771,000; 31Β January 2015: Β£328,904,000) and on 14,542,035 Ordinary Shares (31Β July 2014: 14,817,035; 31Β January 2015: 14,542,035) being the number of Ordinary Shares in issue at the period end.

The diluted net asset value per Ordinary Share is calculated on the assumption that all 30,000 (31Β July 2014: 460,000; 31Β January 2015: 40,000) Share Options in-the-money were exercised at the prevailing exercise prices, giving a total of 14,572,035 issued Ordinary Shares (31Β July 2014: 15,277,035; 31Β January 2015: 14,582,035).

During the period, no Ordinary Shares were bought back for cancellation.

adjustment for Oryx International Growth Fund

On adoption of IFRS 10, the Company has changed its method of accounting for its investment in Oryx. It was previously priced using equity accounting to account for the Company's share of Oryx's net assets. It is now valued using fair value, derived from the share price which is materially different to the value derived from equity accounting.

The below table shows the effect on the net assets of the change in method.

31 July 2015

(unaudited)

Β£'000

31 July 2014

(unaudited)

Β£'000

31 January 2015

(audited)

Β£'000

Total equity attributable to equity holders of theΒ Company

367,545

310,771

328,904

Increase in net assets if equity accounted*

5,898

8,989

5,543

Adjusted net assets

373,443

319,760

334,447

Β 

* increase in net gains on investments at fair value/increase in value of investments at fair value through profit or loss..

31 July 2015

(unaudited)

31 July 2014

(unaudited)

31 January 2015

(audited)

Net asset value

- Basic

2,527p

2,097p

2,262p

- Diluted

2,525p

2,078p

2,259p

Net asset value adjusted

- Basic

2,568p

2,158p

2,300p

- Diluted

2,566p

2,137p

2,297p

Β 

6. share based remuneration

As at 31 July 2015 and as at the date of this report, there were a total of 30,000 options in issue with an estimated fair value of Β£0.4m (31Β July 2014: 460,000; 31Β January 2015: 40,000). 10,000 options are under the 2011 options scheme and 20,000 options are under the 2012 option scheme.

Β 

7. reconciliation of total return from ordinary activities before finance costs and taxation to cash expended from operations

Β 

Six monthsΒ 

ended 31 JulyΒ 

2015Β 

(unaudited)Β 

Β£'000Β 

Six monthsΒ 

ended 31 JulyΒ 

2014Β 

(unaudited)Β 

Β£'000Β 

Year endedΒ 

31 JanuaryΒ 

2015Β 

(audited)Β 

Β£'000Β 

Total return from ordinary activities before finance costs and taxation

38,744Β 

10,121Β 

36,052Β 

Gains on investments

(40,362)

(11,308)

(38,143)

Share options discharge

(103)

-Β 

(3,099)

Share based remuneration

7Β 

180Β 

173Β 

Dividends and interest reinvested

-Β 

77Β 

78Β 

(Increase)/decrease in debtors and accrued income

(186)

(65)

120Β 

Increase/(decrease) in creditors and accruals

1,126Β 

(1,989)

(1,961)

Changes relating to investments of dealing Subsidiary

-Β 

3Β 

(1)

Cash expended from operations

(774)

(2,981)

(6,781)

Β 

8. investments

The Company adopted the amendment to IFRS 13, effective 1 January 2009. This requires the Company to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy consists of the following three levels:

Β· Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1).

An active market is a market in which transactions for the asset or liability occur with sufficient frequency and volume on an ongoing basis such that quoted prices reflect prices at which an orderly transaction would take place between market participants at the measurement date. Quoted prices provided by external pricing services, brokers and vendors are included in Level 1, if they reflect actual and regularly occurring market transactions on an arms length basis.

Β· Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices).

Β· Level 3 - Inputs for the asset or liability that are not based on observable market data (unobservable inputs).

The Company's main unobservable inputs are earnings multiples, recent transactions and net asset basis. The market value would be sensitive to movements in these unobservable inputs. Movements in these inputs, individually or in aggregate could have a significant effect on the market value. The effect of such a change or a reasonable possible alternative would be difficult to quantify as such data is not available.

The level in the fair value hierarchy within which the fair value measurement is categorised in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgement, considering factors specific to the asset or liability.

The determination of what constitutes 'observable' requires significant judgement by the Company. The Company considers observable data from investments actively traded in organised financial markets, fair value is generally determined by reference to Stock Exchange quoted market bid prices at the close of business on the Balance Sheet date, without adjustment for transaction costs necessary to realise the asset.

financial assets at fair value through profit or loss

The table below sets out fair value measurements of financial assets in accordance with the IFRS 13 fair value hierarchy system:

group

six months ended 31 July 2015 (unaudited)

Total

Β£'000

Level 1

Β£'000

Level 2

Β£'000

Level 3

Β£'000

Equity investments

227,352

153,087

2,050

72,215

Fixed interest investments

87,304

65,643

-

21,661

Total

314,656

218,730

2,050

93,876

Β 

six months ended 31 July 2014 (unaudited)

Total

Β£'000

Level 1

Β£'000

Level 2

Β£'000

Level 3

Β£'000

Equity investments

224,963

127,212

1,580

96,171

Fixed interest investments

58,966

53,010

-

5,956

Total

283,929

180,222

1,580

102,127

Β 

year ended 31 January 2015 (audited)

Total

Β£'000

Level 1

Β£'000

Level 2

Β£'000

Level 3

Β£'000

Equity investments

236,596

126,681

1,480

108,435

Fixed interest investments

84,448

65,583

-

18,865

Total

321,044

192,264

1,480

127,300

Β 

Β 

level 3 financial assets at fair value through profit or loss

A reconciliation of fair value measurements in Level 3 is set out below:

group

at 31 July 2015

TotalΒ 

Β£'000Β 

EquityΒ 

investmentsΒ 

Β£'000

Fixed interestΒ 

investmentsΒ 

Β£'000Β 

Opening Balance

127,300Β 

108,435Β 

18,865Β 

Purchases

2,867Β 

37Β 

2,830Β 

Sales

(50,069)

(50,069)

-Β 

Transfer*

(610)

(610)

-Β 

Total gains/(losses) included in gains on investments in the statement of comprehensiveΒ income:

- on assets sold

32,678Β 

32,702Β 

(24)

- on assets held at the end of the period

(18,290)

(18,280)

(10)

Closing balance

93,876Β 

72,215Β 

21,661Β 

Β 

* Transfer out of level 3 to level 1.

First American Holdings was acquired, as part of an initial public offering, by Avenue Financial Holdings Inc. in the period, resulting in a move from unlisted (level 3) to listed (level 1).

9. principal risk profile

The principal risks which the Company faces include exposure to:

(i) market price risk, including currency risk, interest rate risk and other price risk;

(ii) liquidity risk; and

(iii) credit risk.

Further details of the Company's management of these risks and exposure to them is set out in Note 14 of the Company's Annual Report for the year ended 31 January 2015, as issued on 14 May 2015. There have been no changes to the management of or exposure to these risks since that date.

Β 

10. related party transactions

There have been no changes to the related party arrangements or transactions as reported in the Statutory Annual Financial Report for the year ended 31 January 2015.

The Manager, Harwood Capital LLP, is regarded as a related party of the Company. The amounts payable to the Manager and Growth Financial Services Limited in respect of investment management for the six months to 31 July 2015 are as follows:

Six months

ended 31 July

2015

(unaudited)

Β£'000

Six monthsΒ 

ended 31 JulyΒ 

2014Β 

(unaudited)Β 

Β£'000

Year ended

31 January

2015

(audited)

Β£'000

Annual fee

1,672

1,632Β 

3,263

Performance fee

930

-Β 

-

Irrecoverable VAT thereon

7

(26)

(79)

2,609

1,606Β 

3,184

Β 

In addition to the management fees disclosed above, Harwood Capital LLP is also paid an investment management related fee of Β£125,000 per annum.

The figure for the performance fee disclosed above, is a provision for six months based on the outperformance as at 31 July 2015 and is therefore subject to change.

Shareholders should also note the payments made under share based remuneration as disclosed in note 6 to these financial statements.

11. financial information

The annual financial information contained in this half yearly report does not constitute full Statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information for the periods ended 31 July 2015 and 31 July 2014 is not a financial year and has not been audited. The statutory accounts for the financial year ended 31 January 2015 have been delivered to the Registrar of Companies.

Β 

Β 

shareholder information

financial calendar

Announcement of results and annual report May

Annual General Meeting June

Half Yearly figures announced September

Half Yearly Report posted September

share price

The Company's mid-market share price is quoted daily in the Financial Times appearing under "Investment Companies".

It also appears on:

SEAQ Ordinary Shares: NAS

Trustnet: www.trustnet.ltd.uk

net asset value

The latest net asset value of the Company can be found on the HarwoodΒ Capital LLP website: www.harwoodcapital.co.uk

share dealing

Investors wishing to purchase more Ordinary Shares or dispose of all or part of their holding may do so through a stockbroker. Many banks also offer this service.

The Company's registrars are Capita Asset Services. In the event of any queries regarding your holding of shares, please contact the registrars on: 0871 664 0300, or by email on shareholderenquiries@capita.co.uk

Changes of name or address must be notified to the registrars in writing at:

Capita Asset Services

The Registry

34 Beckenham Road

Beckenham

Kent BR3 4TU

Directors

Peregrine Moncreiffe (Chairman)

Christopher Mills (Chief Executive)

Kristian Siem

Charles Irby

Enrique Foster Gittes

Manager

Harwood Capital LLP

(Authorised and regulated by the Financial Conduct Authority)

6 Stratton Street

Mayfair

London W1J 8LD

Telephone: 020 7640 3200

Financial Adviser and Stockbroker

Winterflood Investment Trusts

The Atrium Building

Cannon Bridge

25 Dowgate Hill

London EC4R 2GA

Β 

Registered Office

6 Stratton Street

Mayfair

London W1J 8LD

Telephone: 020 7640 3200

Registrars

Capita Asset Services

34 Beckenham Road

Beckenham

Kent BR3 4TU

Auditors

KPMG LLP

15 Canada Square

London E14 5GL

Company Secretary

Derringtons Limited

Hyde Park House

5 Manfred Road

London SW15 2RS

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR MMGMLNGGGKZM
Date   Source Headline
1st Feb 201611:50 amRNSTransactions in Close Period
19th Jan 201611:19 amRNSDirector/PDMR Shareholding
13th Jan 20164:20 pmRNSNet Asset Value(s)
11th Dec 201512:31 pmRNSNet Asset Value(s)
26th Nov 201511:03 amRNSDirectorate Change
16th Nov 201511:38 amRNSPortfolio Update
10th Nov 20152:26 pmRNSNet Asset Value(s)
5th Nov 201510:48 amRNSTransaction in Own Shares
2nd Nov 201510:38 amRNSHolding(s) in Company
12th Oct 201512:26 pmRNSNet Asset Value(s)
2nd Oct 201512:44 pmRNSHolding(s) in Company
16th Sep 20159:17 amRNSDeath of a Director
15th Sep 20159:54 amRNSNet Asset Value(s)
10th Sep 20156:15 pmRNSHalf Yearly Report
10th Sep 20154:34 pmRNSHolding(s) in Company
12th Aug 201512:46 pmRNSNet Asset Value(s)
17th Jul 20159:39 amRNSNet Asset Value(s)
14th Jul 20159:36 amRNSDirector/PDMR Shareholding
9th Jul 201512:28 pmRNSPortfolio Update
30th Jun 20152:12 pmRNSResult of AGM
11th Jun 20153:31 pmRNSNet Asset Value(s)
26th May 20152:32 pmRNSDoc re. Annual Report
14th May 20156:12 pmRNSFinal Results
13th May 201511:24 amRNSNet Asset Value(s)
29th Apr 201510:11 amRNSHolding(s) in Company
14th Apr 201510:08 amRNSNet Asset Value(s)
2nd Apr 20159:05 amRNSDirector/PDMR Shareholding
1st Apr 20159:21 amRNSDirector/PDMR Shareholding
23rd Mar 201512:43 pmRNSHolding(s) in Company
18th Mar 20153:32 pmRNSNet Asset Value(s)
5th Mar 20159:28 amRNSTransactions in Close Period
2nd Mar 20159:35 amRNSHolding(s) in Company
12th Feb 20155:56 pmRNSNet Asset Value(s)
15th Jan 201510:59 amRNSNet Asset Value(s)
15th Dec 201410:03 amRNSNet Asset Value(s)
10th Dec 20145:13 pmRNSHolding(s) in Company
17th Nov 201410:01 amRNSNet Asset Value(s)
28th Oct 20145:08 pmRNSDirector/PDMR Shareholding
13th Oct 201412:21 pmRNSNet Asset Value(s)
30th Sep 20142:19 pmRNSHalf Yearly Report
24th Sep 201411:09 amRNSHalf Yearly Report
17th Sep 20149:01 amRNSNet Asset Value(s)
10th Sep 20142:49 pmRNSHolding(s) in Company
10th Sep 201410:23 amRNSTransaction in Own Shares
14th Aug 20149:30 amRNSTransaction in Own Shares
13th Aug 20143:44 pmRNSTransactions in a Close Period
11th Aug 201411:16 amRNSNet Asset Value(s)
25th Jul 20142:54 pmRNSTransaction in Own Shares
15th Jul 201411:55 amRNSNet Asset Value(s)
25th Jun 20143:09 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.